--- title: "MicroPort Scientific Flags Return to Profit on Overseas Growth and Cost Cuts" description: "MicroPort Scientific (HK:0853) has announced a positive profit alert, expecting a net profit of at least US$20 million for the year ending December 31, 2025, a turnaround from a net loss of approximat" type: "news" locale: "en" url: "https://longbridge.com/en/news/273397959.md" published_at: "2026-01-22T15:07:49.000Z" --- # MicroPort Scientific Flags Return to Profit on Overseas Growth and Cost Cuts > MicroPort Scientific (HK:0853) has announced a positive profit alert, expecting a net profit of at least US$20 million for the year ending December 31, 2025, a turnaround from a net loss of approximately US$268 million the previous year. This improvement is driven by 70% revenue growth in its overseas business, enhanced gross margins from cost optimization, reduced operating expenses, and gains from subsidiary disposals. The stock currently holds a Hold rating with a price target of HK$11.00, reflecting a significant operational and financial recovery ahead of full results due by March 2026. ### Claim 50% Off TipRanks Premium - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential An announcement from MicroPort Scientific ( (HK:0853) ) is now available. MicroPort Scientific has issued a positive profit alert, stating that it expects to swing to a net profit of at least US$20 million for the year ended 31 December 2025, compared with an audited net loss of about US$268 million a year earlier. The turnaround is attributed to roughly 70% year-on-year revenue growth in its overseas “going‑abroad” business, a 2–3 percentage-point improvement in gross margin from cost optimisation despite domestic pricing pressure in China, a 10–11% reduction in operating expenses through lean management and higher efficiency, and gains from the disposal of subsidiaries, collectively signalling a significant improvement in operational performance and financial health ahead of the full 2025 results due by end-March 2026. The most recent analyst rating on (HK:0853) stock is a Hold with a HK$11.00 price target. To see the full list of analyst forecasts on MicroPort Scientific stock, see the HK:0853 Stock Forecast page. **More about MicroPort Scientific** MicroPort Scientific Corporation is a medical device company based in Shanghai and incorporated in the Cayman Islands, focusing on the research, development and commercialization of innovative medical products. The group is particularly active in selling products developed in China to overseas markets, where its “going‑abroad” business has been a key growth driver, reflecting its strategic emphasis on international expansion within the global medtech industry. **Average Trading Volume:** 15,168,773 **Technical Sentiment Signal:** Hold **Current Market Cap:** HK$22.61B ### Related Stocks - [00853.HK - MICROPORT](https://longbridge.com/en/quote/00853.HK.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | BD 交易与政策红利共振 医药板块 2025 年强势反弹 | 创新药出海与 BD 交易推动医药板块股价爆发,2025 年南向资金净买入达 1.4 万亿港元,港股医疗保健指数年内涨幅 76%。生物医药板块结构性分化显现,具备 First-in-Class 或 Best-in-Class 研发管线的公司更 | [Link](https://longbridge.com/en/news/271855466.md) | | 微创医疗在董事会变动后将 NeuroScientific Corporation 从合并报表中剔除 | 微创医疗科技公司在其董事会中任命了一名独立非执行董事后,已将微创神经科学公司进行去合并。这一变化意味着微创医疗科技不再控制目标公司,但仍保留显著影响力。该公司将根据其股权的公允价值和目标公司的净资产价值确认处置子公司的任何收益,待最终审计审 | [Link](https://longbridge.com/en/news/271118349.md) | | 用 AI 模拟新加坡教师 随时随地帮学生加强数学能力 \| 联合早报网 | WizzTutor 联合创办人徐锦泉和张健伦利用人工智能技术创建了一个在线教育平台,旨在帮助学生随时随地提高数学能力。徐锦泉的创意源于他作为教师时发现学生深夜仍在学习的现象。WizzTutor 提供便捷的在线服务,学生只需使用 iPad 或 | [Link](https://longbridge.com/en/news/276220565.md) | | “硬件防御” 对冲 AI 焦虑,苹果与纳指相关性创 20 年新低 | AI 浪潮下,苹果因未深度卷入军备竞赛,与纳指相关性创 20 年新低,成为科技股动荡中的 “避风港”。在 AI 投资回报存疑及软件业面临颠覆的焦虑中,苹果凭借不易受冲击的硬件生态逆势突围。尽管存在估值偏高及增长放缓压力,其独特的 “AI 中 | [Link](https://longbridge.com/en/news/276301841.md) | | 爱美医疗|10-K:2025 财年营收 6.34 亿美元超过预期 | | [Link](https://longbridge.com/en/news/276485511.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.